Clinical Issues in Chronic Pain: Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling
During this CME-accredited Clinical Issues™ program, a multidisciplinary panel of faculty experts in pain management, rheumatology, neurology, and anesthesiology will examine the mechanistic underpinnings of chronic osteoarthritic and low back pain, focusing on clinically relevant roles of nerve growth factor (NGF) in the potentiation, progression, and severity long-term nociceptive signaling. The panel will also discuss the ongoing—albeit at times interrupted—development of NGF as a therapeutic target. The faculty conversations will be enhanced at times by expert-narrated 3D animations and the latest data published onsite in Vancouver, providing learners with multimedia explanations of new paradigms in chronic pain management.
- Discuss the pathophysiologic underpinnings of chronic osteoarthritic and low back pain with a focus on contributions from NGF
- Educate patients about limitations in efficacy, and personal and public risks associated with currently available pharmacologic treatment options for chronic osteoarthritic or low back pain
- Describe the mechanistic rationales and clinical evidence for emerging analgesic strategies designed to inhibit NGF signaling
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.
This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.
Physician Credit Designation
Global Education Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Americans with Disabilities Act
Global Contact Information
AAPM provided lunch.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Teva Branded Pharmaceutical Products R&D, Inc.